Lubing Gu

2.1k total citations
39 papers, 1.6k citations indexed

About

Lubing Gu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lubing Gu has authored 39 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 21 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in Lubing Gu's work include Cancer-related Molecular Pathways (19 papers), Cell death mechanisms and regulation (11 papers) and Ubiquitin and proteasome pathways (6 papers). Lubing Gu is often cited by papers focused on Cancer-related Molecular Pathways (19 papers), Cell death mechanisms and regulation (11 papers) and Ubiquitin and proteasome pathways (6 papers). Lubing Gu collaborates with scholars based in United States, China and Canada. Lubing Gu's co-authors include Muxiang Zhou, Harry W. Findley, Ningxi Zhu, William G. Woods, Andrew M. Yeager, Fengzhi Li, Sheng Zhou, Jiansha Li, Hailong Zhang and Jing He and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Lubing Gu

39 papers receiving 1.6k citations

Peers

Countries citing papers authored by Lubing Gu

Since Specialization

Citations

This map shows the geographic impact of Lubing Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lubing Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lubing Gu more than expected).

Fields of papers citing papers by Lubing Gu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lubing Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lubing Gu. The network helps show where Lubing Gu may publish in the future.

Co-authorship network of co-authors of Lubing Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Lubing Gu. A scholar is included among the top collaborators of Lubing Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lubing Gu. Lubing Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An MDM2 degrader shows potent cytotoxicity to MDM2-overexpressing acute lymphoblastic leukemia cells with minimal toxicity to normal cells/tissues 2024 ·Cancer Letters ·(unknown), Lubing Gu, (unknown), Zhongzhi Wu, Najah Albadari, Wěi Li, Muxiang Zhou	2
2	Synthesis and biological evaluation of dual MDM2/XIAP inhibitors based on the tetrahydroquinoline scaffold 2023 ·European Journal of Medicinal Chemistry ·Najah Albadari, Yang Xie, Tao Liu, (unknown), Lubing Gu, Muxiang Zhou, Zhongzhi Wu, Wěi Li	4
3	MYCN mRNA degradation and cancer suppression by a selective small-molecule inhibitor in MYCN-amplified neuroblastoma 2022 ·Frontiers in Oncology ·Tao Liu, Lubing Gu, Zhongzhi Wu, Najah Albadari, Wěi Li, Muxiang Zhou	1
4	Upregulation of p53 through induction of MDM2 degradation: Anthraquinone analogs 2019 ·Bioorganic & Medicinal Chemistry ·(unknown), Xiaoxiao Yang, (unknown), (unknown), Chaofeng Dai, Nanting Ni, Weixuan Chen, Zeus A. De los Santos, Lubing Gu, Muxiang Zhou, Binghe Wang	12
5	Inhibition of MDM2 by a Rhein-Derived Compound AQ-101 Suppresses Cancer Development in SCID Mice 2017 ·Molecular Cancer Therapeutics ·Lubing Gu, Hailong Zhang, Tao Liu, (unknown), Sha Yi, Binghe Wang, Muxiang Zhou	24
6	Inhibition of MDM2 homodimerization by XIAP IRES stabilizes MDM2, influencing cancer cell survival 2015 ·Molecular Cancer ·Tao Liu, Hailong Zhang, Jing Xiong, Sha Yi, Lubing Gu, Muxiang Zhou	23
7	Inhibition of MDM2 by Nilotinib Contributes to Cytotoxicity in Both Philadelphia-Positive and Negative Acute Lymphoblastic Leukemia 2014 ·PLoS ONE ·Hailong Zhang, Lubing Gu, Tao Liu, Kuang‐Yueh Chiang, Muxiang Zhou	16
8	Berberine represses DAXX gene transcription and induces cancer cell apoptosis 2013 ·Laboratory Investigation ·Jiansha Li, Lubing Gu, Hailong Zhang, Tao Liu, (unknown), Muxiang Zhou, Sheng Zhou	40
9	Crosstalk between MYCN and MDM2-p53 signal pathways regulates tumor cell growth and apoptosis in neuroblastoma 2011 ·Cell Cycle ·Jing He, Lubing Gu, Hailong Zhang, Muxiang Zhou	39
10	Degradation of MDM2 by the Interaction between Berberine and DAXX Leads to Potent Apoptosis in MDM2-Overexpressing Cancer Cells 2010 ·Cancer Research ·Xiaoling Zhang, Lubing Gu, Jiansha Li, (unknown), Jing He, Lin Yang, Qun Hu, Muxiang Zhou	105
11	Regulation of XIAP Translation and Induction by MDM2 following Irradiation 2009 ·Cancer Cell ·Lubing Gu, Ningxi Zhu, Hongying Zhang, Donald L. Durden, Yue Feng, Muxiang Zhou	140
12	Contribution of STAT3 to the activation of survivin by GM-CSF in CD34+ cell lines 2007 ·Experimental Hematology ·Lubing Gu, Kuang‐Yueh Chiang, Ningxi Zhu, Harry W. Findley, Muxiang Zhou	29
13	KLF5 Interacts with p53 in Regulating Survivin Expression in Acute Lymphoblastic Leukemia 2006 ·Journal of Biological Chemistry ·Ningxi Zhu, Lubing Gu, Harry W. Findley, Ceshi Chen, Jin‐Tang Dong, Lily Yang, Muxiang Zhou	101
14	Transcriptional repression of the eukaryotic initiation factor 4E gene by wild type p53 2005 ·Biochemical and Biophysical Research Communications ·Ningxi Zhu, Lubing Gu, Harry W. Findley, (unknown)	28
15	Loss of PTEN expression induces NF-kB via PI3K/Akt pathway involving resistance to chemotherapy in acute lymphoblastic leukemia cell lines 2004 ·Cancer Research ·Rong Jiang, Lubing Gu, Harry W. Findley, Muxiang Zhou	1
16	Identification and Characterization of the IKKα Promoter 2004 ·Journal of Biological Chemistry ·Lubing Gu, Ningxi Zhu, Harry W. Findley, William G. Woods, Muxiang Zhou	47
17	Transfection of a dominant-negative mutant NF-kB inhibitor (IkBm) represses p53-dependent apoptosis in acute lymphoblastic leukemia cells: interaction of IkBm and p53 2003 ·Oncogene ·Muxiang Zhou, Lubing Gu, Ningxi Zhu, William G. Woods, Harry W. Findley	48
18	DNA Damage Induces a Novel p53-Survivin Signaling Pathway Regulating Cell Cycle and Apoptosis in Acute Lymphoblastic Leukemia Cells 2002 ·Journal of Pharmacology and Experimental Therapeutics ·Muxiang Zhou, Lubing Gu, Fengzhi Li, Yerun Zhu, William G. Woods, Harry W. Findley	118
19	Incidence and Clinical Significance of CDKN2/MTS1/P16^ink4AND MTS2/P15^ink4BGene Deletions in Childhood Acute Lymphoblastic Leukemia 1997 ·Pediatric Hematology and Oncology ·Muxiang Zhou, Lubing Gu, Andrew M. Yeager, Harry W. Findley	32
20	Influence of cytokines and immunosuppressive drugs on major histocompatibility complex class I/II expression by human cardiac myocytes in vitro 1991 ·Human Immunology ·Yichong Wang, Ahvie Herskowitz, Lubing Gu, Kirk R. Kanter, Omar M. Lattouf, Kenneth W. Sell, A. Ahmed‐Ansari	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact